Last updated on November 2019

An Investigational Immuno-therapy Study to Evaluate the Safety and Effectiveness of Experimental Medication BMS-986207 by Itself and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread

Brief description of study

The purpose of this study is to evaluate the safety and effectiveness of experimental medication BMS-986207 by itself and in combination with Nivolumab in solid cancers that are advanced or have spread.

Clinical Study Identifier: NCT02913313

Find a site near you

Start Over

Local Institution

Chuo-ku, Japan
  Connect »